HOME > News Releases

News Releases

2017.02.24
Corporate
PDF/29KB
Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers
2017.01.28
Products
PDF/295KB
Sunovion’s Latuda (lurasidone HCl) Receives FDA Approval to Treat Adolescents with Schizophrenia
2017.01.27
Finances
PDF/558KB
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2017
2017.01.27
Finances
PDF/324KB
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2017 [Japanese GAAP] (Unaudited)
2017.01.26
Corporate
PDF/63KB
Sumitomo Dainippon Pharma Completes Acquisition of Tolero Pharmaceuticals, Inc. (US Biotechnology Company)
2017.01.23
R&D
PDF/161KB
Sumitomo Dainippon Pharma Announces Clinical Data of Investigational Cancer Stemness Inhibitor Napabucasin were presented at 2017 ASCO GI Symposium

Page Top